Due to technical issues, there is no audio for the first 16 minutes of the webcast.

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

The global investment in the fight against HIV and AIDS has increased dramatically over the last decade. Investments in fighting HIV/AIDS offer exceptional return on investment, in terms of the number of lives saved for each dollar spent. Programmes and interventions are getting cheaper, and saving more and more lives, making the global HIV/AIDS response an increasingly attractive investment. However, the savings are not limitless and continued support and increased coordination for HIV treatment, care and prevention programmes are critical to ending the epidemic. The aim of this session is to explore efficiency and effectiveness in the HIV response, both in theory and in practice. The high level panel will consider the definition and relationship between the concepts of efficiency and effectiveness, some of the key lessons that have been learned on the ground and, looking to the future, the prioritization of investment decisions which will need to be made in a world of increasingly restrained resources.

Introduction

•  Dr. Elly Katabira, Uganda

Opening Remarks

• Senator John F. Kerry (D – MA), United States
• Senator Lindsey Graham (R – SC), United States
  

Curtain-raiser video

The business case for investing in HIV: modeling and costing data

• Bill Gates, United States

Ensuring Efficiencies and Effectiveness from a Country Perspective and From the Perspective of the Global Fund

•  Mphu Ramatlapeng, Lesotho

The Impact of USG Investment in HIV and Progress in Maximizing the Impact of This Investment

• Eric Goosby, United States

Remarks

• Jim Yong Kim, United States

Moderated Questions and Answers

• Elly Katabira, Uganda

Event Date

Jul 23, 2012